Cargando…

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants

BACKGROUND: Lupus anticoagulants (LA) are one laboratory criterion for classification of antiphospholipid syndrome, with presence of vascular thrombosis and/or pregnancy/fetal morbidity being clinical criteria. The presence of LA is detected (or excluded) by laboratory testing, with the activated pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Favaloro, Emmanuel J., Pasalic, Leonardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922544/ https://www.ncbi.nlm.nih.gov/pubmed/35316943 http://dx.doi.org/10.1002/rth2.12676

Ejemplares similares

How often are parenteral anticoagulants administered by parents?
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

The new oral anticoagulants and the future of haemostasis laboratory testing
por: Favaloro, Emmanuel J, et al.
Publicado: (2012)

DOAC‐Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples
por: Baker, Steven Andrew, et al.
Publicado: (2021)

Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants
por: Reda, Sara, et al.
Publicado: (2020)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Direct Oral Anticoagulant removal by a DOAC filter: Impact on lupus anticoagulant testing – Evaluation on spiked and patient samples
por: Linskens, Eleni A., et al.
Publicado: (2022)

Dental extractions on direct oral anticoagulants vs. warfarin: The DENTST study
por: Brennan, Yvonne, et al.
Publicado: (2020)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

A multi‐laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Direct Oral Anticoagulants in Dental Patients Including the Frail Elderly Population
por: Lim, Hui Yin, et al.
Publicado: (2016)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Results expression for tests used to measure the anticoagulant effect of new oral anticoagulants
por: Tripodi, Armando
Publicado: (2013)

Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016)

Direct oral anticoagulant: Review article
por: Nasiri, Abdulrahman, et al.
Publicado: (2022)

Direct-acting Oral Anticoagulants: An Overview
por: Salem, Hatem H.
Publicado: (2017)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

The Role of Anticoagulation Clinics in the Era of New Oral Anticoagulants
por: Testa, Sophie, et al.
Publicado: (2012)

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Gastrointestinal bleeding during anticoagulation with direct oral anticoagulants compared to vitamin K antagonists
por: Dongre, Kanchan, et al.
Publicado: (2022)

Anticoagulation for Left Ventricle Thrombus—Case Series and Literature Review for Use of Direct Oral Anticoagulants
por: Pradhan, Akshyaya, et al.
Publicado: (2023)

The prevalence of lupus anticoagulant in normal pregnancy and in women with recurrent fetal loss—recommendations for laboratory testing for lupus anticoagulant
por: Al-Mishari, Abdul Aziz A., et al.
Publicado: (2004)

Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism
por: López-Núñez, Juan J., et al.
Publicado: (2019)

Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants
por: Cullell, Natalia, et al.
Publicado: (2018)

Inherited Thrombophilia in the Era of Direct Oral Anticoagulants
por: Khider, Lina, et al.
Publicado: (2022)

Direct oral anticoagulants: integration into clinical practice
por: Cowell, Richard P W
Publicado: (2014)

Perioperative management of patients on direct oral anticoagulants
por: Dubois, Virginie, et al.
Publicado: (2017)

Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
por: Dunois, Claire
Publicado: (2021)

The Reversal of Direct Oral Anticoagulants in Animal Models
por: Honickel, Markus, et al.
Publicado: (2017)

Drug–Drug Interactions with Direct Oral Anticoagulants
por: Foerster, Kathrin I., et al.
Publicado: (2020)

Overcoming barriers to integrating direct oral anticoagulants into existing anticoagulation management services
por: Sylvester, Katelyn W., et al.
Publicado: (2018)

The Anticoagulated trauma patient in the age of the direct oral anticoagulants: a Canadian perspective
por: Wood, Brendan, et al.
Publicado: (2017)

Current Controversies in Lupus Anticoagulant Detection
por: Moore, Gary W.
Publicado: (2016)

Ruling out lupus anticoagulants with mixing test–specific cutoff assessment and the index of circulating anticoagulant
por: Kumano, Osamu, et al.
Publicado: (2019)

Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
por: Kumano, Osamu, et al.
Publicado: (2021)

Liver injury from direct oral anticoagulants
por: Juneja, Deven, et al.
Publicado: (2023)

Escaping the catch 22 of lupus anticoagulant testing
por: Vinholt, Pernille Just, et al.
Publicado: (2020)

Direct oral anticoagulants‐Remove versus Taipan snake venom time for detection of a lupus anticoagulant in patients taking oral direct factor Xa inhibitors
por: White, Danielle, et al.
Publicado: (2022)

Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation
por: Ferrazzi, Paola, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_lsqi2hj3q6aj1ade5otlb9e6d3